Skip to main content
Caplight Logo









e-NA Biotec Inc.

e-NA Biotec Inc.

Private
JapanHealthcare & Life Scienceshttps://e-nabio.co.jp/

Last Round

Crowdfunding

Nov 12, 2021

Est. Valuation

$6.98M

Total Funding Raised

$260,000

Company Overview

e-NA Biotec Inc. is a biotechnology company that develops microRNA (nucleic acid) medicine for cancer treatment.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

microRNA therapeuticsnucleic acid medicineoligonucleotide therapeuticsRas-targeted therapydrug discoverychemically modified RNAoncology therapeuticsrefractory cancer treatmentbiotech startuppharma licensingnucleic acid designveterinary diagnosticsliquid biopsyAI diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

e-NA Biotec Inc. Comparables

Compare e-NA Biotec Inc. with similar companies based on industry and business-model similarity.

e-NA Biotec Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PURMX Therapeutics
85%
miRaX Therapeutics K.K.
80%
TKG Therapeutics, Inc.
77%

e-NA Biotec Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingNov 12, 2021
GrantJan 11, 2018

e-NA Biotec Inc. Investors

Notable investors and investment history

e-NA Biotec Inc. investors
InvestorRounds
Japan Science and Technology AgencyGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 12, 2021

    Raised $260K in a crowdfunding round.

  • Jan 11, 2018

    Received grant funding from Japan Science and Technology Agency.

e-NA Biotec Inc. Filings

Explore SEC and related filing metadata, where available.

e-NA Biotec Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about e-NA Biotec Inc.'s valuation, stock price, and market status.

Is e-NA Biotec Inc. a public or private company?

e-NA Biotec Inc. is a private company.

What is the current stock price of e-NA Biotec Inc.?

e-NA Biotec Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is e-NA Biotec Inc. worth (valuation)?

e-NA Biotec Inc.'s valuation is estimated at $7.0M based on funding round data.

Can I buy e-NA Biotec Inc. stock?

e-NA Biotec Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was e-NA Biotec Inc.'s last funding round?

e-NA Biotec Inc.'s most recent funding round was Crowdfunding on November 12, 2021.

Who are the main investors in e-NA Biotec Inc.?

Key investors in e-NA Biotec Inc. include Japan Science and Technology Agency.

Will e-NA Biotec Inc. IPO soon?

No public IPO plans have been announced for e-NA Biotec Inc..

How can I track e-NA Biotec Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor e-NA Biotec Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersJapan
Year Founded2018
Last FundingNov 12, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?